Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025)
Tyra Biosciences' (TYRA) quarterly Accumulated Depreciation came in at $1.4 million in Q1 2025, up 50.43% YoY from $926000.0 in Q1 2024, and up 8.74% on a QoQ basis from $1.3 million in Q4 2024.
Tyra Biosciences (TYRA) Accumulated Depreciation (2020 - 2025) Analysis & Trends
Tyra Biosciences (TYRA) has 6 years of Accumulated Depreciation data on file, last reported at $1.4 million in Q1 2025.
- Quarterly Accumulated Depreciation rose 50.43% year-over-year to $1.4 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $1.4 million (up 50.43% YoY) and the FY2024 annual result came in at $1.3 million, up 58.74% from the prior year.
- Accumulated Depreciation advanced to $1.4 million in Q1 2025, from $1.3 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $1.4 million in Q1 2025 to a low of $119000.0 in Q3 2021.
- A 5-year average of $678466.7 and a median of $629000.0 in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2021 — Accumulated Depreciation soared 293.02% — and 2025, when it jumped 50.43%.
- Tracing TYRA's Accumulated Depreciation over 5 years: stood at $169000.0 in 2021, then surged by 172.78% to $461000.0 in 2022, then jumped by 75.05% to $807000.0 in 2023, then soared by 58.74% to $1.3 million in 2024, then increased by 8.74% to $1.4 million in 2025.
- The last three Accumulated Depreciation figures came in at $1.4 million (Q1 2025), $1.3 million (Q4 2024), and $1.2 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tyra Biosciences | 1.51 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 926,000.00 |
| Dec 31, 2023 | 807,000.00 |
| Sep 30, 2023 | 706,000.00 |
| Jun 30, 2023 | 629,000.00 |
| Mar 31, 2023 | 544,000.00 |
| Dec 31, 2022 | 461,000.00 |
| Sep 30, 2022 | 379,000.00 |
| Jun 30, 2022 | 299,000.00 |
| Mar 31, 2022 | 233,000.00 |
| Dec 31, 2021 | 169,000.00 |
| Sep 30, 2021 | 119,000.00 |
| Dec 31, 2020 | 43,000.00 |